Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...
With GLP-1-related drugs having won the race to weight loss approval, attention at many obesity-focused biopharmas has turned ...
One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...
Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...
With weight loss drugs like metformin and Ozempic gaining popularity, it's essential to understand how they compare. So we ...
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...
A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
13d
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback